Back to Search Start Over

Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage.

Authors :
Campanati A
Martina E
Giuliodori K
Bobyr I
Consales V
Offidani A
Source :
Dermatologic therapy [Dermatol Ther] 2019 May; Vol. 32 (3), pp. e12841. Date of Electronic Publication: 2019 Feb 10.
Publication Year :
2019

Abstract

Hidradenitis suppurativa is a chronic skin disease with an intense inflammatory activation. It typically affects the intertriginous areas with cysts, fistulae, and scarring extremely painful. Patients suffer from severe psychological impact. HS still results in a high unmet medical need with several underdiagnosed cases, probably due to the incomplete knowledge of the pathogenesis of HS. The use of botulinum toxin a has recently been proposed as an effective therapy for HS.<br /> (© 2019 Wiley Periodicals, Inc.)

Details

Language :
English
ISSN :
1529-8019
Volume :
32
Issue :
3
Database :
MEDLINE
Journal :
Dermatologic therapy
Publication Type :
Academic Journal
Accession number :
30693648
Full Text :
https://doi.org/10.1111/dth.12841